Status:
UNKNOWN
Intraligamentary Injections and Post-endodontic Pain
Lead Sponsor:
Jamia Millia Islamia
Conditions:
Pulpitis
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
This study will aim to evaluate postoperative pain after intraligamentary injections of dexamethasone (4mg/ml), diclofenac sodium (25mg/ml), 0.5% bupivacaine and 2% lidocaine given to the patients wit...
Detailed Description
The patients will receive a primary Inferior alveolar nerve block injection using 1.8 mL of 2% lidocaine with 1: 80 000 epinephrine using a direct Halsted approach. The needle will be inserted until b...
Eligibility Criteria
Inclusion
- Symptomatic carious exposed mandibular first or second molars.
- Positive and prolonged response to thermal sensitivity tests and electric pulp tests.
- Vital coronal pulp on access cavity preparation.
- American Society of Anesthesiologists class I or II medical history.
- Ability to understand the use of pain scales.
Exclusion
- Active pain in more than 1 tooth
- Teeth with fused roots.
- Radiographic evidence of an extra root.
- Large restorations with overhanging margins.
- Full crowns or deep periodontal pockets.
- Known allergy or contraindications to any content of the local anesthetic solution or NSAIDs
- History of known or suspected drug abuse.
- Taking any drugs which could affect the pain perception, e.g, opioids, antidepressants, anticonvulsants, muscle relaxants, anxiolytics, sedatives, NSAIDs.
- Pregnant or breastfeeding patients.
- Patients with asthma, gastric ulcers, and bleeding disorders.
Key Trial Info
Start Date :
December 2 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 3 2024
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT06186921
Start Date
December 2 2023
End Date
March 3 2024
Last Update
January 2 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Dentistry, Jamia MIliia Islamia
New Delhi, India, 110025